INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Praxis Precision Medicines, Inc. - PRAX
I'm PortAI, I can summarize articles.
Pomerantz Law Firm is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. (NASDAQ: PRAX) regarding potential securities fraud by the company and its officers. This follows Praxis's recent financial report revealing adverse events in a mid-stage study of its anti-seizure medication, leading to a 5.55% drop in stock price. Investors are encouraged to contact Pomerantz for more information about joining the class action.
Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments